Mei Pharma Inc (MEIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2018 | 06-2017 | 06-2016 | 06-2015 | 06-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -40,068 | 2,670 | -20,862 | -32,694 | -27,148 |
| Depreciation Amortization | 53 | 85 | 58 | 64 | 50 |
| Accounts payable and accrued liabilities | 3,058 | -494 | 216 | -845 | 1,171 |
| Other Working Capital | 3,691 | -1,573 | 224 | 338 | 2,900 |
| Other Operating Activity | 12,231 | 2,798 | 2,507 | 5,068 | 3,576 |
| Operating Cash Flow | $-21,035 | $3,486 | $-17,857 | $-28,069 | $-19,451 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -44,327 | -10,026 | 9,976 | -10,041 | -35,016 |
| PPE Investments | N/A | -51 | -4 | -15 | -50 |
| Investing Cash Flow | $-44,327 | $-10,077 | $9,972 | $-10,056 | $-35,066 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 70,480 | 4,212 | N/A | 43,070 | 32,721 |
| Other Financing Activity | -267 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $70,213 | $4,212 | $N/A | $43,070 | $32,721 |
| Beginning Cash Position | 8,458 | 10,837 | 18,722 | 13,777 | 35,573 |
| End Cash Position | 13,309 | 8,458 | 10,837 | 18,722 | 13,777 |
| Net Cash Flow | $4,851 | $-2,379 | $-7,885 | $4,945 | $-21,796 |
| Free Cash Flow | |||||
| Operating Cash Flow | -21,035 | 3,486 | -17,857 | -28,069 | -19,451 |
| Capital Expenditure | 0 | -51 | -4 | -15 | -50 |
| Free Cash Flow | -21,035 | 3,435 | -17,861 | -28,084 | -19,501 |